Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care ...

Breaking down what patients should know about each FDA therapeutic approval from June 2025 across various oncology ...

Waldenström macroglobulinemia is often slow growing, with a 78% five-year survival rate, but chronic conditions can affect ...

Three of five patients with advanced colorectal cancer responded to leronlimab, including one complete response lasting five years, according to new data.

T cells are a natural part of the immune system designed to fight infections and cancer, but in conditions like blood cancer, they may not be able to eliminate malignant cells, according to Dr.

In part 2 of “This Wasn't the Plan,” a young woman recalls her stage 4 blood cancer diagnosis and how chemotherapy revealed ...

During June, investigators reported new data that has advanced the treatment landscape for lung cancer, including new FDA ...

Valarie Traynham discusses some of ways her life has changed since being diagnoses with cancer, and what parts of her ...

After years of survivorship, I’m realizing that shedding extra pounds may do more than improve comfort — it could reduce my ...

Dr. Alexandra Zaleta discusses how most cancer patients face prior authorization delays, despite 95% being approved, ...

Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to ...

Diagnosed with incurable cancer in her 20s, Nathalie Jean rebuilt broken systems in public service — only to face wage theft ...